A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

NCT05142475 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Treatment Side Effects
Advanced Breast Cancer
Effects of Immunotherapy

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL)

Sponsor

Shanghai Juncell Therapeutics

Collaborators

[object Object]